FOLX Health operates a nationwide virtual healthcare platform launched in December 2020, delivering services specifically designed for LGBTQIA+ patients. The platform offers gender-affirming hormone therapy, PrEP for HIV prevention, STI testing, mental health care, primary care, sexual and reproductive health services, and fertility services. The company accepts insurance from major providers including Cigna, Evernorth, and BlueCross BlueShield.
The company was founded by A.G. Breitenstein, a queer health advocate. Eighty-one per cent of clinicians on the platform identify as LGBTQIA+, and the entire executive team comprises members of the community. This composition reflects FOLX Health's stated mission to remove barriers and stigma that have historically prevented quality healthcare access for LGBTQIA+ people.
FOLX Health has received recognition from TIME, which named it one of its Most Influential Companies, and Fast Company, which included it in its Most Innovative Companies list. The platform operates across the United States, addressing a documented need: research cited by the company indicates that 70 per cent of transgender individuals experience healthcare discrimination.
